🇺🇸 FDA
Pipeline program

Digoxin

DECISION trial

Approved small_molecule completed

Quick answer

Digoxin for Heart Failure is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Heart Failure
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials